3-Bromomethyl-3-Ethyl-3,4,6,7,8,8a-Hexahydro-1h-Pyrrolo[2,1-C][1,4]Oxazi Ne-1,4-Dione

Yy Kuang,M Huo,Fe Chen

DOI: https://doi.org/10.1107/S010827010401131X

2004-01-01

Abstract:In the title compound, C10H14BrNO3, the six-membered lactone ring is in a boat conformation, with the two carbonyl groups cis to one another across the boat basal plane. C H...O hydrogen bonds and weak C - H...Br interactions stabilize the crystal structure.

What problem does this paper attempt to address?

3-Bromomethyl-3-ethyl-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[2,1-c][1,4]oxazine-1,4-dione

Yy Kuang,M Huo,Fe Chen

DOI: https://doi.org/10.1107/s010827010401131x

2004-01-01

Abstract:In the title compound, C10H14BrNO3, the six-membered lactone ring is in a boat conformation, with the two carbonyl groups cis to one another across the boat basal plane. C-H...O hydrogen bonds and weak C-H...Br interactions stabilize the crystal structure.
(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

Chao Wu,Yan-Jun Guo,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536813008659

2013-01-01

Abstract:The title compound, C14H14BrNO4, contains a tricyclic ring system including three contiguous stereocenters all of which exhibit an R configuration. The cyclo-hexa-none ring adopts a chair conformation. The central oxane ring assumes a strained envelope conformation, with five of the ring atoms being nearly coplanar with the bromo-phenyl group and with the C atom adjacent to the O atom and fused with the cyclo-hexa-none ring as the flap. In the crystal, mol-ecules are linked into a three-dimensional network by C-H⋯O inter-actions.
(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

Long Zhao,Chao Wu,Wen-Zeng Weng,Chu-Xia Yan,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536812013098

2012-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:The crystal structure of the title compoud, C17H20BrNO3, contains three chiral centers, which all exhibit an S configuration. The C=C double bond has an E conformation. The cyclohexane ring is in a chair conformation. In the crystal, molecules are linked by weak N—O⋯Br interactions [O⋯Br = 3.136 (4) Å].
(S)-2-[(s,z)-3-bromo-1-nitro-4-phenylbut-3-en-2-yl]cyclohexanone

Chao Wu,Long Zhao,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536811025633

2011-01-01

Abstract:In the crystal structure of the title compound, C(16)H(18)BrNO(3), the two stereogenic centres both have an S configuration. The cyclo-hexyl ring adopts a chair conformation. In the crystal, mol-ecules are linked by weak N-O⋯Br contacts [O⋯Br = 3.289 (4) Å].
(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

Qing Yuan,Ming Lei

DOI: https://doi.org/10.1107/s1600536806017296

2006-01-01

Abstract:The absolute configuration of the title compound, C20H26BrNO3, was determined from both the synthetic precursor and anomalous scattering effects. In the crystal structure, non-classical C—H...O hydrogen bonds link the molecules into a sheet parallel to the b axis.
(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Benguo Lin,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536813002560

2013-01-01

Abstract:In the title compound, C(28)H(33)NO(4)·CH(2)Cl(2), the pyrrolidone ring adopts a twisted envelope conformation and the cyclo-hexene has a half-chair conformation. In the crystal, weak C-H⋯O hydrogen bonds link the components into chains along [100].
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809044195

2009-01-01

Abstract:In the title compound, C(28)H(27)NO(2), the oxazinone ring adopts a twist-boat conformation and the cyclo-hexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical inter-molecular C-H⋯O hydrogen bonds.
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1H-2,3-benzoxazin-4-one

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536809044195

2009-01-01

Abstract:In the title compound, C28H27NO2, the oxazinone ring adopts a twist-boat conformation and the cyclohexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical intermolecular C—H...O hydrogen bonds.
(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

Yongzhou Hu,Huazhou Ying

DOI: https://doi.org/10.1107/S1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

Sz Jian,M Lei

DOI: https://doi.org/10.1107/S160053680502845X

2005-01-01

Abstract:In the title compound, C20H21NO3, the dihedral angle between the two benzene rings is 8.79 ( 7)degrees and the cyclohexane ring adopts a chair conformation. The molecules are linked by paired N-H O-... hydrogen bonds into centrosymmetric R-2(2)(8) dimers.
4-Bromo-n-(3,4,5-trimethoxyphenyl)benzamide

N Xue,XY Lu,YZ Hu

DOI: https://doi.org/10.1107/s1600536806014486

2006-01-01

Abstract:In the molecule of the title compound, C16H16BrNO4, the dihedral angle between the planes of the two rings is 16.6 (2)°.
(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Jian Zhao,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017010

2010-01-01

Abstract:The title compound, C(28)H(26)N(2)O(4), crystallizes as a racemate with four stereogenic centers. In the molecule, the pyrrolidone ring adopts an envelope conformation and the cyclohexene ring has a twisted envelope conformation. In the crystal structure, molecules are linked by weak intermolecular C-H center dot center dot center dot O hydrogen bonds.
5-(4-Bromo-anilinomethyl-ene)-2,2-dimethyl-1,3-dioxane-4,6-dione.

Jian-You Shi,Jin-Cheng Yang,Jin-Liang Yang

DOI: https://doi.org/10.1107/s1600536809035776

2009-01-01

Abstract:In the title compound, C(13)H(12)BrNO(4), the dihedral angles between the aminomethylene group and the dioxane ring and between the benzyl ring and the aminomethylene unit are 7.96 (4) and 12.15 (4)degrees, respectively. The dioxane ring shows a half-boat conformation, in which the C atom between the dioxane ring O atoms is 0.460 (8) angstrom out of the plane through the remaining ring atoms. An intramolecular N-H center dot center dot center dot O hydrogen bond may stabilize the planar conformation of the molecule. An intermolecular C-H center dot center dot center dot O interaction is also present.
Ethyl (4aR*,7S*,8S*,8aS*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1H-isochromene-8-carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810017009

2010-01-01

Abstract:In the title compound, C18H20O4, both the tetrahydropyranone ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C—H⋯O hydrogen bonding.
5-Bromo-2-(hydroxymethyl)pyridine

YM Wu,CC Dong,S Liu,HJ Zhu,YZ Wu

DOI: https://doi.org/10.1107/s1600536806015066

2006-01-01

Abstract:The molecule of the title compound, C6H6BrNO, is essentially planar. Intermolecular O—H...Br hydrogen bonds link the molecules into a chain along [101].
N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

Jia-Lu Luo,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809028712

2009-01-01

Abstract:In the title compound, C(29)H(27)N(3)O(5), a dibenz[b,f][1,4]oxazepine derivative, the cyclo-hexane ring adopts a chair conformation, the oxazepine seven-membered ring has a twist-boat conformation, and the piperidin-2-one ring assumes a flattened boat conformation. Inter-molecular N-H⋯O hydrogen bonding between imino and nitro groups links two mol-ecules into a centrosymmetric dimer.
(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

Xing-Rui He,Bing-Rong Xu,Jing-Li Cheng,Jin-Hao Zhao

DOI: https://doi.org/10.1107/S1600536813005138

2013-01-01

Abstract:In the title compound, C18H23NO3, the cyclo-hexane ring has a chair conformation. The oxirane plane (OCC) makes a dihedral angle of 76.15 (13)° with that of the pyrrolidine ring to which it is fused. The mean plane of the cyclo-hexane ring and the benzene ring are almost normal to the pyrrolidine ring, with dihedral angles of 88.47 (8) and 77.85 (8)°, respectively. In the crystal, mol-ecules are linked via pairs of N-H⋯O hydrogen bonds, forming inversion dimers. These dimers are linked via pairs of C-H⋯O hydrogen bonds, forming chains along the a-axis direction.
rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

Ning Ye,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536812005946

2012-01-01

Abstract:In the title compound, C(31)H(29)ClN(2)O(3), the two heterocyclic rings, belonging to a system of five condensed rings, adopt conformations intermediate between twist-boat and sofa. The secondary amide group is involved in a weak intramolecular N-H⋯N hydrogen bond. In the crystal, molecules are linked by pairs of C-H⋯Cl hydrogen bonds to form inversion dimers. These dimers are linked via a C-H⋯O interaction to form chains propagating along the b-axis direction.
4-P-tolyl-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidin-2-one

L Yan,YL Zhu,YJ Pan

DOI: https://doi.org/10.1107/s1600536805008147

2005-01-01

Abstract:The title compound, C14H18N2O2, which was obtained from an extended Biginelli reaction, contains a pyran ring with a chair conformation, a pyrimidine ring with a half-chair conformation and a benzene ring. The crystal structure is stabilized by an intermolecular hydrogen-bond network involving both NH groups and the carbonyl group.
4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidi Ne-2-Thione

L Yan,YL Zhu,YJ Pan

DOI: https://doi.org/10.1107/s1600536805010068

2005-01-01

Abstract:The title compound, C14H18N2O2S, which was obtained from an extended Biginelli reaction, contains a pyran ring with a chair conformation, a pyrimidine ring with a half-chair conformation and a benzene ring. The crystal structure is stabilized by an intermolecular hydrogen-bond network.

3-Bromomethyl-3-Ethyl-3,4,6,7,8,8a-Hexahydro-1h-Pyrrolo[2,1-C][1,4]Oxazi Ne-1,4-Dione

3-Bromomethyl-3-ethyl-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[2,1-c][1,4]oxazine-1,4-dione

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

(S)-2-[(s,z)-3-bromo-1-nitro-4-phenylbut-3-en-2-yl]cyclohexanone

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

4-Bromo-n-(3,4,5-trimethoxyphenyl)benzamide

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

5-(4-Bromo-anilinomethyl-ene)-2,2-dimethyl-1,3-dioxane-4,6-dione.

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

5-Bromo-2-(hydroxymethyl)pyridine

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

4-P-tolyl-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidin-2-one

4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidi Ne-2-Thione

3-Bromomethyl-3-Ethyl-3,4,6,7,8,8a-Hexahydro-1h-Pyrrolo[2,1-C][1,4]Oxazi Ne-1,4-Dione

3-Bromomethyl-3-ethyl-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[2,1-c][1,4]oxazine-1,4-dione

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

(S)-2-[(s,z)-3-bromo-1-nitro-4-phenylbut-3-en-2-yl]cyclohexanone

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>*,4a<i>R</i>*,5<i>S</i>*,6<i>S</i>*,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

4-Bromo-n-(3,4,5-trimethoxyphenyl)benzamide

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

5-(4-Bromo-anilinomethyl-ene)-2,2-dimethyl-1,3-dioxane-4,6-dione.

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

5-Bromo-2-(hydroxymethyl)pyridine

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

4-P-tolyl-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidin-2-one

4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidi Ne-2-Thione

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate